Spectrophotometric intracutaneous analysis versus dermoscopy for the diagnosis of pigmented skin lesions: prospective, double-blind study in a secondary reference centre

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Spectrophotometric intracutaneous analysis versus dermoscopy for the diagnosis of pigmented skin lesions: prospective, double-blind study in a secondary reference centre. / Glud, Martin; Gniadecki, Robert; Drzewiecki, Krzysztof T.

In: Melanoma Research, Vol. 19, No. 3, 01.06.2009, p. 176-9.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Glud, M, Gniadecki, R & Drzewiecki, KT 2009, 'Spectrophotometric intracutaneous analysis versus dermoscopy for the diagnosis of pigmented skin lesions: prospective, double-blind study in a secondary reference centre', Melanoma Research, vol. 19, no. 3, pp. 176-9. https://doi.org/10.1097/CMR.0b013e328322fe5f, https://doi.org/10.1097/CMR.0b013e328322fe5f

APA

Glud, M., Gniadecki, R., & Drzewiecki, K. T. (2009). Spectrophotometric intracutaneous analysis versus dermoscopy for the diagnosis of pigmented skin lesions: prospective, double-blind study in a secondary reference centre. Melanoma Research, 19(3), 176-9. https://doi.org/10.1097/CMR.0b013e328322fe5f, https://doi.org/10.1097/CMR.0b013e328322fe5f

Vancouver

Glud M, Gniadecki R, Drzewiecki KT. Spectrophotometric intracutaneous analysis versus dermoscopy for the diagnosis of pigmented skin lesions: prospective, double-blind study in a secondary reference centre. Melanoma Research. 2009 Jun 1;19(3):176-9. https://doi.org/10.1097/CMR.0b013e328322fe5f, https://doi.org/10.1097/CMR.0b013e328322fe5f

Author

Glud, Martin ; Gniadecki, Robert ; Drzewiecki, Krzysztof T. / Spectrophotometric intracutaneous analysis versus dermoscopy for the diagnosis of pigmented skin lesions: prospective, double-blind study in a secondary reference centre. In: Melanoma Research. 2009 ; Vol. 19, No. 3. pp. 176-9.

Bibtex

@article{a4f1f8c0890411df928f000ea68e967b,
title = "Spectrophotometric intracutaneous analysis versus dermoscopy for the diagnosis of pigmented skin lesions: prospective, double-blind study in a secondary reference centre",
abstract = "Dermoscopy is considered to be the golden standard for the clinical assessment of pigmented skin lesions. In expert hands, this instrument improves both sensitivity and specificity for the diagnosis of melanoma, however, the outcome is highly dependent on the skills and experience of the examiner. Spectrophotometric intracutaneous analysis (SIAscopy) is a new, commercially available method of analyzing pigmented skin lesions noninvasively. The diagnosis is based on objective features such as the presence of dermal pigment, vascularity of the lesion, and the integrity of collagen. The objective of this study was to examine the usefulness of SIAscopy for the clinical diagnosis of malignant melanoma in a prospective, unbiased manner. We enrolled 65 patients with 83 lesions, where the diagnosis of melanoma could not be ruled out on the basis of the clinical evaluation by a nondermatologist. All lesions were investigated by dermoscopy and SIAscopy and subsequently excised. Histopathologically, 12 lesions were diagnosed as malignant melanoma. Both dermoscopy and SIAscopy overestimated the proportion of possible malignant lesions (n=24 and 41, respectively) and had sensitivities of 92 and 100%, respectively. The specificity of dermoscopy in this study was 81% against 59% for SIAscopy. Our result shows that dermoscopy remains the best diagnostic tool for the preoperative diagnosis of pigmented skin lesions. However, as the SIAscope in addition to the SIAgraph images produces dermoscopic images, it holds the advantages in training and archiving.",
author = "Martin Glud and Robert Gniadecki and Drzewiecki, {Krzysztof T}",
note = "Times Cited: 0ArticleEnglishGlud, MUniv Copenhagen, Rigshosp, Fac Hlth Sci, Dept Plast Surg, Blegdamsvej 9, DK-2100 Copenhagen, DenmarkCited References Count: 16451MGLIPPINCOTT WILLIAMS & WILKINS530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USAPHILADELPHIA",
year = "2009",
month = jun,
day = "1",
doi = "10.1097/CMR.0b013e328322fe5f",
language = "English",
volume = "19",
pages = "176--9",
journal = "Melanoma Research",
issn = "0960-8931",
publisher = "Lippincott Williams & Wilkins, Ltd.",
number = "3",

}

RIS

TY - JOUR

T1 - Spectrophotometric intracutaneous analysis versus dermoscopy for the diagnosis of pigmented skin lesions: prospective, double-blind study in a secondary reference centre

AU - Glud, Martin

AU - Gniadecki, Robert

AU - Drzewiecki, Krzysztof T

N1 - Times Cited: 0ArticleEnglishGlud, MUniv Copenhagen, Rigshosp, Fac Hlth Sci, Dept Plast Surg, Blegdamsvej 9, DK-2100 Copenhagen, DenmarkCited References Count: 16451MGLIPPINCOTT WILLIAMS & WILKINS530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USAPHILADELPHIA

PY - 2009/6/1

Y1 - 2009/6/1

N2 - Dermoscopy is considered to be the golden standard for the clinical assessment of pigmented skin lesions. In expert hands, this instrument improves both sensitivity and specificity for the diagnosis of melanoma, however, the outcome is highly dependent on the skills and experience of the examiner. Spectrophotometric intracutaneous analysis (SIAscopy) is a new, commercially available method of analyzing pigmented skin lesions noninvasively. The diagnosis is based on objective features such as the presence of dermal pigment, vascularity of the lesion, and the integrity of collagen. The objective of this study was to examine the usefulness of SIAscopy for the clinical diagnosis of malignant melanoma in a prospective, unbiased manner. We enrolled 65 patients with 83 lesions, where the diagnosis of melanoma could not be ruled out on the basis of the clinical evaluation by a nondermatologist. All lesions were investigated by dermoscopy and SIAscopy and subsequently excised. Histopathologically, 12 lesions were diagnosed as malignant melanoma. Both dermoscopy and SIAscopy overestimated the proportion of possible malignant lesions (n=24 and 41, respectively) and had sensitivities of 92 and 100%, respectively. The specificity of dermoscopy in this study was 81% against 59% for SIAscopy. Our result shows that dermoscopy remains the best diagnostic tool for the preoperative diagnosis of pigmented skin lesions. However, as the SIAscope in addition to the SIAgraph images produces dermoscopic images, it holds the advantages in training and archiving.

AB - Dermoscopy is considered to be the golden standard for the clinical assessment of pigmented skin lesions. In expert hands, this instrument improves both sensitivity and specificity for the diagnosis of melanoma, however, the outcome is highly dependent on the skills and experience of the examiner. Spectrophotometric intracutaneous analysis (SIAscopy) is a new, commercially available method of analyzing pigmented skin lesions noninvasively. The diagnosis is based on objective features such as the presence of dermal pigment, vascularity of the lesion, and the integrity of collagen. The objective of this study was to examine the usefulness of SIAscopy for the clinical diagnosis of malignant melanoma in a prospective, unbiased manner. We enrolled 65 patients with 83 lesions, where the diagnosis of melanoma could not be ruled out on the basis of the clinical evaluation by a nondermatologist. All lesions were investigated by dermoscopy and SIAscopy and subsequently excised. Histopathologically, 12 lesions were diagnosed as malignant melanoma. Both dermoscopy and SIAscopy overestimated the proportion of possible malignant lesions (n=24 and 41, respectively) and had sensitivities of 92 and 100%, respectively. The specificity of dermoscopy in this study was 81% against 59% for SIAscopy. Our result shows that dermoscopy remains the best diagnostic tool for the preoperative diagnosis of pigmented skin lesions. However, as the SIAscope in addition to the SIAgraph images produces dermoscopic images, it holds the advantages in training and archiving.

U2 - 10.1097/CMR.0b013e328322fe5f

DO - 10.1097/CMR.0b013e328322fe5f

M3 - Journal article

C2 - 19319002

VL - 19

SP - 176

EP - 179

JO - Melanoma Research

JF - Melanoma Research

SN - 0960-8931

IS - 3

ER -

ID: 20656896